| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4113549
Max Phase: Preclinical
Molecular Formula: C26H25ClN4O5
Molecular Weight: 508.96
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: N=C(N)Nc1ccc(C(=O)Oc2ccc(CCC(=O)N[C@H](CC(=O)O)c3ccccc3)c(Cl)c2)cc1
Standard InChI: InChI=1S/C26H25ClN4O5/c27-21-14-20(36-25(35)18-6-10-19(11-7-18)30-26(28)29)12-8-16(21)9-13-23(32)31-22(15-24(33)34)17-4-2-1-3-5-17/h1-8,10-12,14,22H,9,13,15H2,(H,31,32)(H,33,34)(H4,28,29,30)/t22-/m1/s1
Standard InChI Key: JQKDSSFGHMMYHD-JOCHJYFZSA-N
Associated Targets(Human)
Trypsin I 2306 Activities
Trypsin 2137 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 508.96 | Molecular Weight (Monoisotopic): 508.1513 | AlogP: 4.13 | #Rotatable Bonds: 10 |
| Polar Surface Area: 154.60 | Molecular Species: ACID | HBA: 5 | HBD: 5 |
| #RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 3.84 | CX Basic pKa: 8.39 | CX LogP: 2.56 | CX LogD: 2.52 |
| Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.12 | Np Likeness Score: -0.70 |
References
| 1. (2015) Guanidinobenzoic acid compound, |
Source
Source(1):